Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EMIT-2b: Evaluating Modes of Influenza Transmission Through the Conduct of Controlled Human Influenza Virus Infection Transmission Trials (CHIVITTs)

NCT07342556 is registered in ClinicalTrials.gov with University of Maryland, College Park as lead sponsor.

NCT NCT07342556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07342556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EMIT-2b: Evaluating Modes of Influenza Transmission Through the Conduct of Controlled Human Influenza Virus Infection Transmission Trials (CHIVITTs)
Lead sponsor
University of Maryland, College Park
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
May 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza (healthy volunteers)